Literature DB >> 17086476

Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.

J Honegger1, U Ernemann, T Psaras, B Will.   

Abstract

BACKGROUND: Despite ample experience with transsphenoidal surgery, objective data on which suprasellar tumour expansion and growth pattern allows for radical adenoma resection are still sparse. Hence, we have performed a prospective study to establish the predictive value of tumour dimension and shape for the intra-operative descent of the diaphragma, the completeness of tumour resection and the outcome of patients harbouring pituitary adenomas with suprasellar extension.
METHOD: Included in the study were 105 patients with nonfunctioning pituitary adenomas and suprasellar extension who underwent primary transsphenoidal surgery between January 1998 and December 2005. The precise suprasellar extension, the degree of dumbbell-shape, the configuration of the adenomas and the depth of the pituitary fossa were evaluated. Completeness of resection was assessed by MRI at 3 months postoperatively.
FINDINGS: The mean cranio-caudal diameter of the tumours was 28.0 mm (range 9.2-57.8 mm). On average, the suprasellar extension measured 11.9 mm (range 2.1-25.8 mm). Total removal of the suprasellar tumour was accomplished in 83% (87 of 105) of the patients. A second operation for residual adenoma was only indicated in 2 cases. The vertical intracranial extension was the strongest independent predictor of subtotal resection (p < 0.001). Irregular and multilobular configuration was a second highly-significant and independent predictor for incomplete resection (p < 0.003). In contrast, dumbbell-shape and shallow pituitary fossa were not independent predictive factors for incomplete tumour resection. The complication rate was very low. None of our patients suffered postoperative rhinorrhea, meningitis or visual deterioration.
CONCLUSIONS: One-stage transsphenoidal surgery allows total or near-total resection of most suprasellar pituitary adenomas with low surgical morbidity. Quantitative assessment of tumour dimension and configuration contributes to establishing guidelines for the selection of the appropriate approach and prediction of surgical outcome.

Entities:  

Mesh:

Year:  2006        PMID: 17086476     DOI: 10.1007/s00701-006-1044-6

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

Review 1.  Optimal management of non-functioning pituitary adenomas.

Authors:  Yona Greenman; Naftali Stern
Journal:  Endocrine       Date:  2015-07-16       Impact factor: 3.633

2.  The current role of transcranial surgery in the management of pituitary adenomas.

Authors:  Ravindran Pratheesh; Simon Rajaratnam; Krishna Prabhu; Sunithi E Mani; Geeta Chacko; Ari G Chacko
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

3.  Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery.

Authors:  Christoph P Hofstetter; Michael J Nanaszko; Lynn L Mubita; John Tsiouris; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

4.  Transoral robotic-assisted skull base surgery to approach the sella turcica: cadaveric study.

Authors:  Dorian Chauvet; Antoine Missistrano; Mikaël Hivelin; Alexandre Carpentier; Philippe Cornu; Stéphane Hans
Journal:  Neurosurg Rev       Date:  2014-05-22       Impact factor: 3.042

Review 5.  Radiotherapy of nonfunctioning and gonadotroph adenomas.

Authors:  Andrew A Kanner; Benjamin W Corn; Yona Greenman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

6.  Craniocaudal extension as an indication of surgical outcome in transsphenoidal surgery for pituitary adenomas.

Authors:  Ossama Hamid; Adel El Hakim; Hossam El Husseiny; Lobna El Fiky; Sherif Kamel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-27

Review 7.  Non-functioning pituitary adenomas: growth and aggressiveness.

Authors:  Kristin Astrid Øystese; Johan Arild Evang; Jens Bollerslev
Journal:  Endocrine       Date:  2016-04-11       Impact factor: 3.633

8.  Combined simultaneous transcranial and transsphenoidal resection of large-to-giant pituitary adenomas.

Authors:  Gilberto Ka Kit Leung; Hing Yu Law; Kwun Ngai Hung; Yiu Wah Fan; Wai Man Lui
Journal:  Acta Neurochir (Wien)       Date:  2011-04-30       Impact factor: 2.216

9.  Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas.

Authors:  Marta Araujo-Castro; Héctor Pian; Ignacio Ruz-Caracuel; Alberto Acitores Cancela; Eider Pascual-Corrales; Víctor Rodríguez Berrocal
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

10.  Relationship with the diaphragm to predict the surgical outcome in large and giant pituitary adenomas.

Authors:  Ethan Harel; Giulia Cossu; Roy Thomas Daniel; Mahmoud Messerer
Journal:  Front Surg       Date:  2022-09-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.